Učitavanje...
Drug Companies Worry About New “Totality of Evidence” Standard: Is It an About–Face From the FDA on Off-Label Promotion?
Drug companies worry about new FDA “totality of evidence” standard
Spremljeno u:
| Izdano u: | P T |
|---|---|
| Glavni autor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MediMedia USA, Inc.
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5398619/ https://ncbi.nlm.nih.gov/pubmed/28479835 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|